Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Mosca

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Expert Opinion on Biological Therapy|January 9, 2003
Immunoregulatory T cells in cancer immunotherapyMichael A Morse, Timothy M Clay, Paul Mosca, et al.
Journal of the American College of Surgeons|February 18, 2014
Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanomaGeorgia M Beasley, Paul Speicher, Ketan Sharma, et al.
Melanoma Research|June 17, 2016
A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapyLisa Kottschade, Adam Brys, Tobias Peikert, et al.
Annals of Surgical Oncology|April 6, 2012
Patterns of recurrence following complete response to regional chemotherapy for in-transit melanomaKetan Sharma, Georgia Beasley, Ryan Turley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2009
Targeting Akt3 signaling in malignant melanoma using isoselenocyanatesArati Sharma, Arun K Sharma, Subbarao V Madhunapantula, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Expert Opinion on Biological Therapy|January 9, 2003
Immunoregulatory T cells in cancer immunotherapyMichael A Morse, Timothy M Clay, Paul Mosca, et al.
Journal of the American College of Surgeons|February 18, 2014
Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanomaGeorgia M Beasley, Paul Speicher, Ketan Sharma, et al.
Melanoma Research|June 17, 2016
A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapyLisa Kottschade, Adam Brys, Tobias Peikert, et al.
Annals of Surgical Oncology|April 6, 2012
Patterns of recurrence following complete response to regional chemotherapy for in-transit melanomaKetan Sharma, Georgia Beasley, Ryan Turley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2009
Targeting Akt3 signaling in malignant melanoma using isoselenocyanatesArati Sharma, Arun K Sharma, Subbarao V Madhunapantula, et al.
Pageof 1